NASDAQ · BNGO
Bionano Genomics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BNGO: Nov 10, 2026
Bionano Genomics, Inc. Common Stock is expected to report earnings on 11/10/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.56. The reported EPS for the same quarter last year was $-1.59.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.56 | $-0.56 | $-0.56 | 1 |
| Dec 2026 | $-0.49 | $-0.49 | $-0.49 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Zacks- RTTNews · Sep 14, 2:17 PM EDTBiotech Stocks On The Move: Tyra, Nasus, Bionano & Tenaya Make Gains(RTTNews) – Several biotech stocks were in focus Monday, including Tyra Biosciences following a $400 million stock and warrant offering to advance its dabogratinib 3×3 strategy; Nasus Pharma after FDA clearance of its IND for intranasal epinephrine NS002; Bionano Genomics followi
- RTTNews · Sep 14, 11:36 AM EDTBionano: OGM Studies Reveal High-Risk Genomic Alterations Missed By Standard Cytogenetics(RTTNews) – Bionano Genomics, Inc. (BNGO) announced that three independently authored, peer-reviewed studies have demonstrated that optical genome mapping (OGM) can uncover clinically significant structural genomic alterations across myelodysplastic syndromes (MDS), acute myeloid
- RTTNews · Sep 10, 10:50 AM EDTBionano Announces Proposed Medicare Coverage For Genome-Wide Hematologic Cancer Testing(RTTNews) – Bionano Genomics, Inc. (BNGO), through its wholly owned subsidiary Bionano Laboratories, announced that MolDX has issued a proposed Local Coverage Determination (LCD) for genome-wide molecular methodologies used to detect copy number alterations and structural variant
- The Motley Fool · Aug 17, 5:14 PM EDTBionano Genomics (BNGO) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Jun 8, 12:00 PM EDTBionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock?Bionano Genomics (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- The Motley Fool · Jun 2, 12:59 PM EDTBionano (BNGO) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 28, 8:55 AM EDTWhy Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value InvestorsBionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
- Zacks · May 13, 5:35 PM EDTBionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue EstimatesBionano Genomics (BNGO) delivered earnings and revenue surprises of +6.17% and +2.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 12, 8:30 AM EDTArvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue EstimatesArvinas (ARVN) delivered earnings and revenue surprises of +5.01% and -0.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 8:50 AM EDTLexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Mar 23, 6:25 PM EDTBionano Genomics (BNGO) Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Jan 23, 9:40 AM ESTIs Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?Here is how Black Diamond (BDTX) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Bionano Genomics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.